drugset / Trial / NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NaSingle-groupSingle-blindTreatment
Summary
This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.
Timeline
- Start
- 2025-06-26
- Primary completion
- 2027-04-30
- Completion
- 2028-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adecatumumab | Monoclonal antibody | — | Intravenous |
| Subject | MT-501 | Unknown | — | — |